McCarter & English, LLP
Dihydropyrrolopyridine inhibitors of ROR-gamma
Provided are novel compounds of Formula (I):pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by ROR. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
Vitae Pharmaceuticals, Inc.
A A A A A A A A A A A A A A A A A A A A A A A A A A C A A A A A A A
A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Lawrence Wayne Yajun Colin M. Wei Lanqi David A. Chengguo Andrew Stephen D. Linghang Suresh B. Jing Yi
Dillard Zheng Tice Zhao Jia Claremon Dong Marcus Lotesta Zhuang Singh Yuan Fan